PEPTIDES UNDER THE MICROSCOPE — The new roster of the FDA's advisory panel on drug compounding contains several members who would benefit from the agency endorsing broader use of peptides and other alternative wellness treatments, Lauren writes. The advisory panel helps give non-binding advice to the FDA on compounding, a practice where a pharmacy or facility alters a drug to meet the needs of an individual patient.